CLINICAL DECISION SUPPORT
PharmAlert reads the whole patient — medicines, allergies, renal and hepatic function, pregnancy, age and conditions — and flags what actually matters, with the reason and a safer alternative.
Patient · F · 74 · eGFR 42 · Penicillin allergy
THE PROBLEM
Most prescribing systems alert on the drug, not the patient. The same warning appears whether the person in front of you is 24 and healthy or 84 with reduced renal function, and it appears every time. So the warnings get dismissed — including the one that mattered.
Medication errors remain one of the leading causes of preventable patient harm. The gap isn't a lack of warnings. It's a lack of context.
LEGACY SYSTEM · 14 alerts
PHARMALERT · 1 alert, with reasoning
At this level of renal function the maximum metformin dose is reduced, typically to 1 g daily in divided doses.
Well documented · Established
SuggestedReduce the dose and review renal function every three to six months — confirm against local guidance.
THE PLATFORM
PharmAlert evaluates a prescription against the patient it is written for. It identifies clinically significant risks, explains why each one was raised, suggests a safer alternative where one exists, and records the decision when a clinician chooses to proceed. The judgement stays with the clinician. The checking doesn't have to.
THE PROCESS
The patient's full clinical picture — current medicines, allergies, renal and hepatic function, pregnancy status, age and conditions.
Every medicine is checked against the patient, not just against the other drugs — interactions, dosing, contraindications, duplication.
Findings are ranked by clinical significance and patient context. What needs attention comes first. What doesn't stays out of the way.
Each alert carries its reason, its evidence and a safer alternative where one exists. Proceeding is always available, and always recorded.
TRY IT
This is the checking logic, running live. Adjust the patient, add or remove medicines, and see exactly what PharmAlert would raise — and why.
PRIORITISATION
PharmAlert ranks findings by three things: how serious the risk is, how much the patient's own circumstances change that risk, and how well established the evidence behind it is. A theoretical interaction in a healthy 30-year-old is not the same finding as the same interaction in an 82-year-old with reduced renal function — and it shouldn't look the same on screen.
Overridden alerts stay in the record but move out of the way. The reasoning behind every ranking is visible, because a check nobody can inspect is a check nobody will trust.
PharmAlert supports the decision. It does not make it.
UNSORTED · 14 findings
WHO IT'S FOR
PARTNERSHIPS
PharmAlert is being developed with healthcare providers, research institutions and health authorities who want to shape how medication safety checking should work — and who are prepared to test it properly before it reaches patients.
Pilot the platform in a live setting and help evaluate its clinical impact.
Connect PharmAlert to existing prescribing, ePMA and pharmacy systems.
Collaborate on medication safety research, teaching and national programmes.
A globally trusted medication safety platform —
helping clinicians prevent preventable harm
through intelligent, evidence-based decision support.
PharmAlert™ · Clinical Decision Support
GET IN TOUCH
We work with hospitals, primary care organisations, pharmacy groups, universities and health authorities. Tell us about your setting and we'll come back with what a pilot would look like for you.
What to expect